APO Research
Talk to an analyst

APO RESEARCH · REPORT

On-Site Coronavirus Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global On-Site Coronavirus Testing Service Market Outlook and Growth Opportunities 2026

16 January 2026190 pages

Choose your research edition.

Industry ResearchOn-Site Coronavirus Testing Service Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal On-Site Coronavirus Testing Service Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal On-Site Coronavirus Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal On-Site Coronavirus Testing Service Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal On-Site Coronavirus Testing Service Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global On-Site Coronavirus Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for On-Site Coronavirus Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for On-Site Coronavirus Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for On-Site Coronavirus Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the On-Site Coronavirus Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the On-Site Coronavirus Testing Service market include AB Medical Services (UK) Limited, Total Testing Solutions, CVS Health, CareCube, We Are Lifeline Health, EventScan, Fern Health Check, Live Better Solutions and BeCore, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global On-Site Coronavirus Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of On-Site Coronavirus Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents On-Site Coronavirus Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global On-Site Coronavirus Testing Service market.

On-Site Coronavirus Testing Service Segment by Company

AB Medical Services (UK) Limited

Total Testing Solutions

CVS Health

CareCube

We Are Lifeline Health

EventScan

Fern Health Check

Live Better Solutions

BeCore

Alliance Nationwide Exposition

Covid Clinic

GENETWORx

Collinson Group

Prenetics

On-Site Coronavirus Testing Service Segment by Type

Throat Swab Testing

Nasal Swab Testing

Saliva Testing

On-Site Coronavirus Testing Service Segment by Application

Workplace

Large Event Site

Tourist Attraction

Other

On-Site Coronavirus Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global On-Site Coronavirus Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the On-Site Coronavirus Testing Service key companies, revenue, market share, and recent developments.

3. To split the On-Site Coronavirus Testing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions On-Site Coronavirus Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify On-Site Coronavirus Testing Service significant trends, drivers, influence factors in global and regions.

6. To analyze On-Site Coronavirus Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global On-Site Coronavirus Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of On-Site Coronavirus Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of On-Site Coronavirus Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global On-Site Coronavirus Testing Service industry.

Chapter 3: Detailed analysis of On-Site Coronavirus Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of On-Site Coronavirus Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of On-Site Coronavirus Testing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. On-Site Coronavirus Testing Service Industry Trends Table 2. On-Site Coronavirus Testing Service Industry Drivers Table 3. On-Site Coronavirus Testing Service Industry Opportunities and Challenges Table 4. On-Site Coronavirus Testing Service Industry Restraints Table 5. Global On-Site Coronavirus Testing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global On-Site Coronavirus Testing Service Revenue Share by Company (2021-2026) Table 7. Global On-Site Coronavirus Testing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global On-Site Coronavirus Testing Service Key Company Manufacturing Base & Headquarters Table 9. Global On-Site Coronavirus Testing Service Company, Product Type & Application Table 10. Global On-Site Coronavirus Testing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global On-Site Coronavirus Testing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Throat Swab Testing Table 15. Significant Companies of Nasal Swab Testing Table 16. Significant Companies of Saliva Testing Table 17. Global On-Site Coronavirus Testing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global On-Site Coronavirus Testing Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global On-Site Coronavirus Testing Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global On-Site Coronavirus Testing Service Sales Value Share by Type (2021-2026) Table 21. Global On-Site Coronavirus Testing Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Workplace Table 23. Significant Companies of Large Event Site Table 24. Significant Companies of Tourist Attraction Table 25. Significant Companies of Other Table 26. Global On-Site Coronavirus Testing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global On-Site Coronavirus Testing Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global On-Site Coronavirus Testing Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global On-Site Coronavirus Testing Service Sales Value Share by Application (2021-2026) Table 30. Global On-Site Coronavirus Testing Service Sales Value Share by Application (2027-2032) Table 31. Global On-Site Coronavirus Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global On-Site Coronavirus Testing Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global On-Site Coronavirus Testing Service Sales Value Share by Region (2021-2026) Table 34. Global On-Site Coronavirus Testing Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global On-Site Coronavirus Testing Service Sales Value Share by Region (2027-2032) Table 36. Global On-Site Coronavirus Testing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global On-Site Coronavirus Testing Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global On-Site Coronavirus Testing Service Sales Value Market Share by Country (2021-2026) Table 39. Global On-Site Coronavirus Testing Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global On-Site Coronavirus Testing Service Sales Value Market Share by Country (2027-2032) Table 41. AB Medical Services (UK) Limited Company Information Table 42. AB Medical Services (UK) Limited Business Overview Table 43. AB Medical Services (UK) Limited On-Site Coronavirus Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. AB Medical Services (UK) Limited On-Site Coronavirus Testing Service Product Portfolio Table 45. AB Medical Services (UK) Limited Recent Development Table 46. Total Testing Solutions Company Information Table 47. Total Testing Solutions Business Overview Table 48. Total Testing Solutions On-Site Coronavirus Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Total Testing Solutions On-Site Coronavirus Testing Service Product Portfolio Table 50. Total Testing Solutions Recent Development Table 51. CVS Health Company Information Table 52. CVS Health Business Overview Table 53. CVS Health On-Site Coronavirus Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. CVS Health On-Site Coronavirus Testing Service Product Portfolio Table 55. CVS Health Recent Development Table 56. CareCube Company Information Table 57. CareCube Business Overview Table 58. CareCube On-Site Coronavirus Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. CareCube On-Site Coronavirus Testing Service Product Portfolio Table 60. CareCube Recent Development Table 61. We Are Lifeline Health Company Information Table 62. We Are Lifeline Health Business Overview Table 63. We Are Lifeline Health On-Site Coronavirus Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. We Are Lifeline Health On-Site Coronavirus Testing Service Product Portfolio Table 65. We Are Lifeline Health Recent Development Table 66. EventScan Company Information Table 67. EventScan Business Overview Table 68. EventScan On-Site Coronavirus Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. EventScan On-Site Coronavirus Testing Service Product Portfolio Table 70. EventScan Recent Development Table 71. Fern Health Check Company Information Table 72. Fern Health Check Business Overview Table 73. Fern Health Check On-Site Coronavirus Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Fern Health Check On-Site Coronavirus Testing Service Product Portfolio Table 75. Fern Health Check Recent Development Table 76. Live Better Solutions Company Information Table 77. Live Better Solutions Business Overview Table 78. Live Better Solutions On-Site Coronavirus Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Live Better Solutions On-Site Coronavirus Testing Service Product Portfolio Table 80. Live Better Solutions Recent Development Table 81. BeCore Company Information Table 82. BeCore Business Overview Table 83. BeCore On-Site Coronavirus Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. BeCore On-Site Coronavirus Testing Service Product Portfolio Table 85. BeCore Recent Development Table 86. Alliance Nationwide Exposition Company Information Table 87. Alliance Nationwide Exposition Business Overview Table 88. Alliance Nationwide Exposition On-Site Coronavirus Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Alliance Nationwide Exposition On-Site Coronavirus Testing Service Product Portfolio Table 90. Alliance Nationwide Exposition Recent Development Table 91. Covid Clinic Company Information Table 92. Covid Clinic Business Overview Table 93. Covid Clinic On-Site Coronavirus Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Covid Clinic On-Site Coronavirus Testing Service Product Portfolio Table 95. Covid Clinic Recent Development Table 96. GENETWORx Company Information Table 97. GENETWORx Business Overview Table 98. GENETWORx On-Site Coronavirus Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. GENETWORx On-Site Coronavirus Testing Service Product Portfolio Table 100. GENETWORx Recent Development Table 101. Collinson Group Company Information Table 102. Collinson Group Business Overview Table 103. Collinson Group On-Site Coronavirus Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Collinson Group On-Site Coronavirus Testing Service Product Portfolio Table 105. Collinson Group Recent Development Table 106. Prenetics Company Information Table 107. Prenetics Business Overview Table 108. Prenetics On-Site Coronavirus Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Prenetics On-Site Coronavirus Testing Service Product Portfolio Table 110. Prenetics Recent Development Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. On-Site Coronavirus Testing Service Product Image Figure 2. Global On-Site Coronavirus Testing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global On-Site Coronavirus Testing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global On-Site Coronavirus Testing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Throat Swab Testing Image Figure 8. Nasal Swab Testing Image Figure 9. Saliva Testing Image Figure 10. Global On-Site Coronavirus Testing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global On-Site Coronavirus Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global On-Site Coronavirus Testing Service Sales Value Share by Type (2021-2032) Figure 13. Workplace Image Figure 14. Large Event Site Image Figure 15. Tourist Attraction Image Figure 16. Other Image Figure 17. Global On-Site Coronavirus Testing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global On-Site Coronavirus Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global On-Site Coronavirus Testing Service Sales Value Share by Application (2021-2032) Figure 20. Global On-Site Coronavirus Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global On-Site Coronavirus Testing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America On-Site Coronavirus Testing Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America On-Site Coronavirus Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe On-Site Coronavirus Testing Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe On-Site Coronavirus Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific On-Site Coronavirus Testing Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific On-Site Coronavirus Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America On-Site Coronavirus Testing Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America On-Site Coronavirus Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa On-Site Coronavirus Testing Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa On-Site Coronavirus Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Throat Swab Testing
  • Nasal Swab Testing
  • Saliva Testing
Applications
  • Workplace
  • Large Event Site
  • Tourist Attraction
  • Other
Companies covered
  • AB Medical Services (UK) Limited
  • Total Testing Solutions
  • CVS Health
  • CareCube
  • We Are Lifeline Health
  • EventScan
  • Fern Health Check
  • Live Better Solutions
  • BeCore
  • Alliance Nationwide Exposition
  • Covid Clinic
  • GENETWORx
  • Collinson Group
  • Prenetics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global On-Site Coronavirus Testing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global On-Site Coronavirus Testing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 On-Site Coronavirus Testing Service Market Dynamics
  1. 2.1 On-Site Coronavirus Testing Service Industry Trends
  2. 2.2 On-Site Coronavirus Testing Service Industry Drivers
  3. 2.3 On-Site Coronavirus Testing Service Industry Opportunities and Challenges
  4. 2.4 On-Site Coronavirus Testing Service Industry Restraints
3 On-Site Coronavirus Testing Service Market by Company
  1. 3.1 Global On-Site Coronavirus Testing Service Company Revenue Ranking in 2025
  2. 3.2 Global On-Site Coronavirus Testing Service Revenue by Company (2021-2026)
  3. 3.3 Global On-Site Coronavirus Testing Service Company Ranking (2024-2026)
  4. 3.4 Global On-Site Coronavirus Testing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global On-Site Coronavirus Testing Service Company Product Type and Application
  6. 3.6 Global On-Site Coronavirus Testing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global On-Site Coronavirus Testing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 On-Site Coronavirus Testing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 On-Site Coronavirus Testing Service Market by Type
  1. 4.1 On-Site Coronavirus Testing Service Type Introduction
  2. 4.1.1 Throat Swab Testing
  3. 4.1.2 Nasal Swab Testing
  4. 4.1.3 Saliva Testing
  5. 4.2 Global On-Site Coronavirus Testing Service Sales Value by Type
  6. 4.2.1 Global On-Site Coronavirus Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global On-Site Coronavirus Testing Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global On-Site Coronavirus Testing Service Sales Value Share by Type (2021-2032)
5 On-Site Coronavirus Testing Service Market by Application
  1. 5.1 On-Site Coronavirus Testing Service Application Introduction
  2. 5.1.1 Workplace
  3. 5.1.2 Large Event Site
  4. 5.1.3 Tourist Attraction
  5. 5.1.4 Other
  6. 5.2 Global On-Site Coronavirus Testing Service Sales Value by Application
  7. 5.2.1 Global On-Site Coronavirus Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global On-Site Coronavirus Testing Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global On-Site Coronavirus Testing Service Sales Value Share by Application (2021-2032)
6 On-Site Coronavirus Testing Service Regional Value Analysis
  1. 6.1 Global On-Site Coronavirus Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global On-Site Coronavirus Testing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global On-Site Coronavirus Testing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global On-Site Coronavirus Testing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America On-Site Coronavirus Testing Service Sales Value (2021-2032)
  7. 6.3.2 North America On-Site Coronavirus Testing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe On-Site Coronavirus Testing Service Sales Value (2021-2032)
  10. 6.4.2 Europe On-Site Coronavirus Testing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific On-Site Coronavirus Testing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific On-Site Coronavirus Testing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America On-Site Coronavirus Testing Service Sales Value (2021-2032)
  16. 6.6.2 South America On-Site Coronavirus Testing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa On-Site Coronavirus Testing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa On-Site Coronavirus Testing Service Sales Value Share by Country, 2025 VS 2032
7 On-Site Coronavirus Testing Service Country-level Value Analysis
  1. 7.1 Global On-Site Coronavirus Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global On-Site Coronavirus Testing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global On-Site Coronavirus Testing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global On-Site Coronavirus Testing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt On-Site Coronavirus Testing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt On-Site Coronavirus Testing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt On-Site Coronavirus Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AB Medical Services (UK) Limited
  2. 8.1.1 AB Medical Services (UK) Limited Company Information
  3. 8.1.2 AB Medical Services (UK) Limited Business Overview
  4. 8.1.3 AB Medical Services (UK) Limited On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AB Medical Services (UK) Limited On-Site Coronavirus Testing Service Product Portfolio
  6. 8.1.5 AB Medical Services (UK) Limited Recent Developments
  7. 8.2 Total Testing Solutions
  8. 8.2.1 Total Testing Solutions Company Information
  9. 8.2.2 Total Testing Solutions Business Overview
  10. 8.2.3 Total Testing Solutions On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Total Testing Solutions On-Site Coronavirus Testing Service Product Portfolio
  12. 8.2.5 Total Testing Solutions Recent Developments
  13. 8.3 CVS Health
  14. 8.3.1 CVS Health Company Information
  15. 8.3.2 CVS Health Business Overview
  16. 8.3.3 CVS Health On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CVS Health On-Site Coronavirus Testing Service Product Portfolio
  18. 8.3.5 CVS Health Recent Developments
  19. 8.4 CareCube
  20. 8.4.1 CareCube Company Information
  21. 8.4.2 CareCube Business Overview
  22. 8.4.3 CareCube On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CareCube On-Site Coronavirus Testing Service Product Portfolio
  24. 8.4.5 CareCube Recent Developments
  25. 8.5 We Are Lifeline Health
  26. 8.5.1 We Are Lifeline Health Company Information
  27. 8.5.2 We Are Lifeline Health Business Overview
  28. 8.5.3 We Are Lifeline Health On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 We Are Lifeline Health On-Site Coronavirus Testing Service Product Portfolio
  30. 8.5.5 We Are Lifeline Health Recent Developments
  31. 8.6 EventScan
  32. 8.6.1 EventScan Company Information
  33. 8.6.2 EventScan Business Overview
  34. 8.6.3 EventScan On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 EventScan On-Site Coronavirus Testing Service Product Portfolio
  36. 8.6.5 EventScan Recent Developments
  37. 8.7 Fern Health Check
  38. 8.7.1 Fern Health Check Company Information
  39. 8.7.2 Fern Health Check Business Overview
  40. 8.7.3 Fern Health Check On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Fern Health Check On-Site Coronavirus Testing Service Product Portfolio
  42. 8.7.5 Fern Health Check Recent Developments
  43. 8.8 Live Better Solutions
  44. 8.8.1 Live Better Solutions Company Information
  45. 8.8.2 Live Better Solutions Business Overview
  46. 8.8.3 Live Better Solutions On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Live Better Solutions On-Site Coronavirus Testing Service Product Portfolio
  48. 8.8.5 Live Better Solutions Recent Developments
  49. 8.9 BeCore
  50. 8.9.1 BeCore Company Information
  51. 8.9.2 BeCore Business Overview
  52. 8.9.3 BeCore On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BeCore On-Site Coronavirus Testing Service Product Portfolio
  54. 8.9.5 BeCore Recent Developments
  55. 8.10 Alliance Nationwide Exposition
  56. 8.10.1 Alliance Nationwide Exposition Company Information
  57. 8.10.2 Alliance Nationwide Exposition Business Overview
  58. 8.10.3 Alliance Nationwide Exposition On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Alliance Nationwide Exposition On-Site Coronavirus Testing Service Product Portfolio
  60. 8.10.5 Alliance Nationwide Exposition Recent Developments
  61. 8.11 Covid Clinic
  62. 8.11.1 Covid Clinic Company Information
  63. 8.11.2 Covid Clinic Business Overview
  64. 8.11.3 Covid Clinic On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Covid Clinic On-Site Coronavirus Testing Service Product Portfolio
  66. 8.11.5 Covid Clinic Recent Developments
  67. 8.12 GENETWORx
  68. 8.12.1 GENETWORx Company Information
  69. 8.12.2 GENETWORx Business Overview
  70. 8.12.3 GENETWORx On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 GENETWORx On-Site Coronavirus Testing Service Product Portfolio
  72. 8.12.5 GENETWORx Recent Developments
  73. 8.13 Collinson Group
  74. 8.13.1 Collinson Group Company Information
  75. 8.13.2 Collinson Group Business Overview
  76. 8.13.3 Collinson Group On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Collinson Group On-Site Coronavirus Testing Service Product Portfolio
  78. 8.13.5 Collinson Group Recent Developments
  79. 8.14 Prenetics
  80. 8.14.1 Prenetics Company Information
  81. 8.14.2 Prenetics Business Overview
  82. 8.14.3 Prenetics On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Prenetics On-Site Coronavirus Testing Service Product Portfolio
  84. 8.14.5 Prenetics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst